Mangoceuticals shares surge 108.64% intraday after board reprices CEO's stock options to $0.45 per share covering 2.13M shares to enhance management incentives.

Mangoceuticals surged 108.64% intraday as the board approved repricing of CEO Jacob Cohen's stock options to $0.45 per share, covering 2,133,333 shares to enhance management incentives. The company develops and markets male health products via telemedicine in the U.S., including brands for erectile dysfunction, hair loss, hormone balance, and weight loss.